FindTrial
Sign In

A study of clinical application for counter-incision undermining in the management of intersphincteric fistula

A study of clinical application for counter-incision undermining in the management of intersphincteric fistula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009774
Enrollment
Unknown
Registered
2016-11-07
Start date
2017-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intersphincteric Fistula

Interventions

Treatment group:counterincision
comparison group:anal fistulectomy

Sponsors

Shuguang hospital affiliated to Shanghai university of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosed with intersphincteric fistula, aged 18 to 60 years old hospitalized patients, men and women there is no limit, a total of 60 cases.

Exclusion criteria

Exclusion criteria: Patient who has a history of the anus surgery or trauma; Pregnancy and lactation women; Malignant tumor; Specific infections (e.g. tuberculosis, crohn's disease and ulcerative colitis); With other crissum diseases such as mixed hemorrhoids, anal fissure, perianal eczema.

Design outcomes

Primary

MeasureTime frame
symptom score;overall curative effect evaluation;symptom curative effect evaluation;healing time;anus function evaluation;—

Countries

China

Contacts

Public ContactDe Zheng

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

zd1232@sina.com+86 13641763662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026